"10.1371_journal.pmed.0050114","plos medicine","2008-05-27T00:00:00Z","Timothy A Chan; Sabine Glockner; Joo Mi Yi; Wei Chen; Leander Van Neste; Leslie Cope; James G Herman; Victor Velculescu; Kornel E Schuebel; Nita Ahuja; Stephen B Baylin","Cancer Biology Program, The Johns Hopkins Kimmel Cancer Center, Baltimore, Maryland, United States of America; Department of Radiation Oncology and Molecular Radiation Sciences, The Johns Hopkins Kimmel Cancer Center, Baltimore, Maryland, United States of America; Department of Surgery, Johns Hopkins Hospital, Baltimore, Maryland, United States of America; Predoctoral Training Program in Human Genetics, The Johns Hopkins University, Baltimore, Maryland, United States of America; Department of Molecular Biotechnology, Ghent University, Ghent, Belgium; Biometry and Clinical Trials Division, The Johns Hopkins Kimmel Cancer Center, Baltimore, Maryland, United States of America; Ludwig Center for Cancer Genetics and Therapeutics, The Johns Hopkins Kimmel Cancer Center, Baltimore, Maryland, United States of America; Howard Hughes Medical Institute at The Johns Hopkins Kimmel Cancer Center, Baltimore, Maryland, United States of America","TAC and SBB designed the study. TAC and SG performed the experiments for the study. TAC, VV, KES, and SBB analyzed the data and interpreted the results. TAC, WC, LVN, LC, and JGH contributed bioinformatics and statistical analysis to the research effort. TAC and SBB wrote the manuscript. NA enrolled patients and helped analyze the clinical outcomes data. JMY performed a portion of the bisulfite sequencing analysis of the common target.","The authors have declared that no competing interests exist.","2008","05","Timothy A Chan","TAC",11,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA
